| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |